DENTSPLY SIRONA (XRAY) Stock Forecast & Price Target

Compare

545 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

XRAY Analyst Ratings

Hold

2 Buy

13 Hold

1 Sell

Based on 16 analysts giving stock ratings to

DENTSPLY

SIRONA

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

XRAY Stock 12 Month Forecast

Average Price Target

$13.18

▲(15.92% Upside)

Based on 16 Wall Street analysts offering 12 month price targets for DENTSPLY SIRONA in the last 3 months. The average price target is $13.18 with a high forecast of $17.00 and a low forecast of $12.00. The average price target represents a 15.92% change from the last price of $11.37.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"10":"$10","15":"$15","20":"$20","12.5":"$12.5","17.5":"$17.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":17,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$17.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13.18,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$13.18</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$12.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[10,12.5,15,17.5,20],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.18,11.627692307692307,12.075384615384616,12.523076923076923,12.97076923076923,13.418461538461539,13.866153846153846,14.313846153846153,14.76153846153846,15.20923076923077,15.656923076923077,16.104615384615386,16.552307692307693,{"y":17,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.18,11.333846153846153,11.487692307692308,11.641538461538461,11.795384615384615,11.94923076923077,12.103076923076923,12.256923076923076,12.41076923076923,12.564615384615385,12.718461538461538,12.872307692307693,13.026153846153846,{"y":13.18,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.18,11.243076923076924,11.306153846153846,11.36923076923077,11.432307692307692,11.495384615384616,11.558461538461538,11.621538461538462,11.684615384615384,11.747692307692308,11.81076923076923,11.873846153846154,11.936923076923076,{"y":12,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":19.01,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.36,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.11,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.01,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.32,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.61,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.26,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.33,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 34, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.12,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.63,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 33, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.95,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.61,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.18,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$17.00

Average Price Target$13.18

Lowest Price Target$12.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Jeff Johnson

Robert W. Baird

$14→$12

Hold

5.54%

Upside

Reiterated

12/16/25

Dentsply Sirona price target lowered to $12 from $14 at BairdDentsply Sirona price target lowered to $12 from $14 at Baird

Michael Petusky

Barrington

$14

Buy

23.13%

Upside

Reiterated

12/16/25

DENTSPLY SIRONA: Strategic R&D Investments and Market Recovery Potential Drive Buy Rating

Glen Santangelo

Barclays

$12

Sell

5.54%

Upside

Initiated

12/08/25

Dentsply Sirona initiated with an Underweight at BarclaysDentsply Sirona initiated with an Underweight at Barclays

Kevin Caliendo

UBS

$23→$17

Buy

49.52%

Upside

Reiterated

11/10/25

UBS Remains a Buy on DENTSPLY SIRONA (XRAY)

Erin Wright

Morgan Stanley

$14→$12

Hold

5.54%

Upside

Reiterated

11/07/25

Dentsply Sirona price target lowered to $12 from $14 at Morgan StanleyDentsply Sirona price target lowered to $12 from $14 at Morgan Stanley

Vik Chopra

Wells Fargo

$12

Hold

5.54%

Upside

Reiterated

11/07/25

Analysts Offer Insights on Healthcare Companies: Dexcom (NASDAQ: DXCM) and DENTSPLY SIRONA (NASDAQ: XRAY)

Brandon Vazquez

William Blair

Hold

―

Downgraded

11/07/25

Analysts Offer Insights on Healthcare Companies: DENTSPLY SIRONA (NASDAQ: XRAY) and 4D Molecular Therapeutics (NASDAQ: FDMT)

Lilia-Celine (Lily) Lozada

J.P. Morgan

$14→$12

Hold

5.54%

Upside

Reiterated

11/07/25

Dentsply Sirona price target lowered to $12 from $14 at JPMorganDentsply Sirona price target lowered to $12 from $14 at JPMorgan

Steven Valiquette

Mizuho Securities

$16→$13

Hold

14.34%

Upside

Reiterated

11/07/25

Dentsply Sirona price target lowered to $13 from $16 at MizuhoDentsply Sirona price target lowered to $13 from $16 at Mizuho

Jason Bednar

Piper Sandler

$16→$13

Hold

14.34%

Upside

Reiterated

11/07/25

Dentsply Sirona price target lowered to $13 from $16 at Piper SandlerDentsply Sirona price target lowered to $13 from $16 at Piper Sandler

Jonathan Block

Stifel Nicolaus

$15→$13

Hold

14.34%

Upside

Reiterated

11/06/25

Dentsply Sirona price target lowered to $13 from $15 at StifelDentsply Sirona price target lowered to $13 from $15 at Stifel

David Saxon

Needham

Hold

―

Reiterated

11/06/25

DENTSPLY SIRONA: Hold Rating Amid Strategic Investments and Revised Growth Outlook

Allen Lutz

Bank of America Securities

$17→$15

Hold

31.93%

Upside

Reiterated

10/24/25

Dentsply Sirona price target lowered to $15 from $17 at BofADentsply Sirona price target lowered to $15 from $17 at BofA

Michael Cherny

Leerink Partners

$14.5→$13.5

Hold

18.73%

Upside

Reiterated

10/14/25

Leerink Partners Remains a Hold on DENTSPLY SIRONA (XRAY)

Michael Sarcone

Jefferies

$15→$13

Hold

14.34%

Upside

Reiterated

10/10/25

Jefferies Sticks to Its Hold Rating for DENTSPLY SIRONA (XRAY)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Jeff Johnson

Robert W. Baird

$14→$12

Hold

5.54%

Upside

Reiterated

12/16/25

Dentsply Sirona price target lowered to $12 from $14 at BairdDentsply Sirona price target lowered to $12 from $14 at Baird

Michael Petusky

Barrington

$14

Buy

23.13%

Upside

Reiterated

12/16/25

DENTSPLY SIRONA: Strategic R&D Investments and Market Recovery Potential Drive Buy Rating

Glen Santangelo

Barclays

$12

Sell

5.54%

Upside

Initiated

12/08/25

Dentsply Sirona initiated with an Underweight at BarclaysDentsply Sirona initiated with an Underweight at Barclays

Kevin Caliendo

UBS

$23→$17

Buy

49.52%

Upside

Reiterated

11/10/25

UBS Remains a Buy on DENTSPLY SIRONA (XRAY)

Erin Wright

Morgan Stanley

$14→$12

Hold

5.54%

Upside

Reiterated

11/07/25

Dentsply Sirona price target lowered to $12 from $14 at Morgan StanleyDentsply Sirona price target lowered to $12 from $14 at Morgan Stanley

Vik Chopra

Wells Fargo

$12

Hold

5.54%

Upside

Reiterated

11/07/25

Analysts Offer Insights on Healthcare Companies: Dexcom (NASDAQ: DXCM) and DENTSPLY SIRONA (NASDAQ: XRAY)

Brandon Vazquez

William Blair

Hold

―

Downgraded

11/07/25

Analysts Offer Insights on Healthcare Companies: DENTSPLY SIRONA (NASDAQ: XRAY) and 4D Molecular Therapeutics (NASDAQ: FDMT)

Lilia-Celine (Lily) Lozada

J.P. Morgan

$14→$12

Hold

5.54%

Upside

Reiterated

11/07/25

Dentsply Sirona price target lowered to $12 from $14 at JPMorganDentsply Sirona price target lowered to $12 from $14 at JPMorgan

Steven Valiquette

Mizuho Securities

$16→$13

Hold

14.34%

Upside

Reiterated

11/07/25

Dentsply Sirona price target lowered to $13 from $16 at MizuhoDentsply Sirona price target lowered to $13 from $16 at Mizuho

Jason Bednar

Piper Sandler

$16→$13

Hold

14.34%

Upside

Reiterated

11/07/25

Dentsply Sirona price target lowered to $13 from $16 at Piper SandlerDentsply Sirona price target lowered to $13 from $16 at Piper Sandler

Jonathan Block

Stifel Nicolaus

$15→$13

Hold

14.34%

Upside

Reiterated

11/06/25

Dentsply Sirona price target lowered to $13 from $15 at StifelDentsply Sirona price target lowered to $13 from $15 at Stifel

David Saxon

Needham

Hold

―

Reiterated

11/06/25

DENTSPLY SIRONA: Hold Rating Amid Strategic Investments and Revised Growth Outlook

Allen Lutz

Bank of America Securities

$17→$15

Hold

31.93%

Upside

Reiterated

10/24/25

Dentsply Sirona price target lowered to $15 from $17 at BofADentsply Sirona price target lowered to $15 from $17 at BofA

Michael Cherny

Leerink Partners

$14.5→$13.5

Hold

18.73%

Upside

Reiterated

10/14/25

Leerink Partners Remains a Hold on DENTSPLY SIRONA (XRAY)

Michael Sarcone

Jefferies

$15→$13

Hold

14.34%

Upside

Reiterated

10/10/25

Jefferies Sticks to Its Hold Rating for DENTSPLY SIRONA (XRAY)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering DENTSPLY SIRONA

1 Month

xxx

Success Rate

13/36 ratings generated profit

Average Return

-2.64%

reiterated a xxx

rating 2 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 36.11% of your transactions generating a profit, with an average return of -2.64% per trade.

3 Months

xxx

Success Rate

10/36 ratings generated profit

Average Return

-6.21%

reiterated a xxx

rating 2 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 27.78% of your transactions generating a profit, with an average return of -6.21% per trade.

1 Year

Michael PetuskyBarrington

Success Rate

4/36 ratings generated profit

Average Return

-24.19%

reiterated a buy rating 2 days ago

Copying Michael Petusky's trades and holding each position for 1 Year would result in 11.11% of your transactions generating a profit, with an average return of -24.19% per trade.

2 Years

xxx

Success Rate

1/36 ratings generated profit

Average Return

-37.38%

reiterated a xxx

rating 2 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 2.78% of your transactions generating a profit, with an average return of -37.38% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

XRAY Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, XRAY has received 5 Buy Ratings, 20 Hold Ratings, and 2 Sell Ratings. XRAY average Analyst price target in the past 3 months is 13.18.

Each month's total comprises the sum of three months' worth of ratings.

XRAY Financial Forecast

XRAY Earnings Forecast

Next quarter’s earnings estimate for XRAY is $0.29 with a range of $0.25 to $0.44. The previous quarter’s EPS was $0.37. XRAY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year XRAY has Performed in-line its overall industry.

XRAY Sales Forecast

Next quarter’s sales forecast for XRAY is $927.41M with a range of $892.00M to $964.00M. The previous quarter’s sales results were $904.00M. XRAY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year XRAY has Performed in-line its overall industry.

XRAY Stock Forecast FAQ

What is XRAY’s average 12-month price target, according to analysts?

Based on analyst ratings, DENTSPLY SIRONA Inc’s 12-month average price target is 13.18.

What is XRAY’s upside potential, based on the analysts’ average price target?

DENTSPLY SIRONA Inc has 15.92% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is XRAY a Buy, Sell or Hold?

DENTSPLY SIRONA Inc has a consensus rating of Hold which is based on 2 buy ratings, 13 hold ratings and 1 sell ratings.

What is DENTSPLY SIRONA Inc’s price target?

The average price target for DENTSPLY SIRONA Inc is 13.18. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $17.00 ,the lowest forecast is $12.00. The average price target represents 15.92% Increase from the current price of $11.37.

What do analysts say about DENTSPLY SIRONA Inc?

DENTSPLY SIRONA Inc’s analyst rating consensus is a Hold. This is based on the ratings of 16 Wall Streets Analysts.

How can I buy shares of XRAY?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

DENTSPLY SIRONA (XRAY) Stock Forecast & Price Target

XRAY Analyst Ratings

XRAY Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering DENTSPLY SIRONA

XRAY Analyst Recommendation Trends

XRAY Financial Forecast

XRAY Earnings Forecast

XRAY Sales Forecast

XRAY Stock Forecast FAQ

Detailed List of Analyst Forecasts